혈관 실링 디바이스 시장 보고서 : 제품별, 용도별, 최종사용자별, 지역별(2025-2033년)

The global vessel sealing devices market size reached USD 2.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.5 Billion by 2033, exhibiting a growth rate (CAGR) of 5.77% during 2025-2033. The market is propelled by rising prevalence of chronic diseases, technological advancements in surgical instruments, particularly in vessel sealing devices, and the increasing preference for minimally invasive surgeries.

Vessel Sealing Devices Market Analysis:

• Major Market Drivers: The rise in chronic diseases such as cardiovascular diseases, cancer, and obesity-related conditions is a primary driver for the vessel sealing devices market. These conditions often require surgical interventions, necessitating the use of vessel sealing devices to ensure effective hemostasis during surgery
• Key Market Trends: There is a notable trend toward the integration of advanced energy-based technologies in vessel sealing devices, such as ultrasonic and bipolar energy. These technologies offer improved precision and reduced thermal spread, enhancing surgical safety and efficacy.
• Geographical Trends: North America accounts for the largest vessel sealing devices market share due to high healthcare expenditure, advanced healthcare infrastructure, and the early adoption of innovative surgical technologies.
• Competitive Landscape: Some of the major market players in the vessel sealing devices industry include B. Braun Melsungen AG, BOWA-electronic GmbH & Co. KG, Erbe Elektromedizin GmbH, Hologic Inc., Intuitive Surgical Inc., Johnson & Johnson, KLS Martin Group, Lamidey Noury Medical, Medtronic plc, Olympus Corporation, OmniGuide Holdings Inc. and Xcellance Medical Technologies Private Limited, among many others.
• Challenges and Opportunities: As per the vessel sealing devices market forecast the high cost of advanced vessel sealing devices can be a barrier to adoption, particularly in developing regions where healthcare budgets are limited. Besides, continuous innovation and the development of new, advanced vessel sealing devices offer substantial growth opportunities.

Vessel Sealing Devices Market Trends:

Rising prevalence of chronic diseases

The rising frequency of chronic diseases like cancer, cardiovascular problems, and obesity is a major driver of the vessel sealing devices market growth. As these illnesses frequently require surgical procedures, there is an increased demand for sophisticated surgical equipment that can improve procedural efficacy and safety. As per Centers of Diseases Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease including heart disease, cancer, diabetes, obesity, and hypertension. Besides, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Vessel sealing devices are especially important in procedures involving substantial tissue manipulation and hemostasis because they offer consistent sealing of blood vessels and tissue bundles, reducing intraoperative blood loss and postoperative problems. The growing burden of chronic diseases around the world, combined with the aging population, magnifies the need for surgical treatments, boosting the demand for effective vessel sealing solutions.

Increasing adoption of minimally invasive surgeries

Another key element creating a favorable vascular sealing devices market outlook is the transition to minimally invasive surgical (MIS) procedures. According to National Library of Medicine, in 2017, 9.8 million inpatient major operating room procedures were analyzed, of which 11.1% were MIS and 2.5% were robotic-assisted, compared with 9.6 million inpatient operating room procedures (11.2% MIS and 2.9% robotic-assisted) in 2018. Minimally invasive procedures, such as laparoscopic and robotic surgeries, have various advantages over traditional open surgeries, including less postoperative pain, shorter hospital stays, faster recovery times, and a lower chance of complications. Vessel sealing devices are essential for MIS procedures because they enable precise and successful hemostasis in limited surgical fields. The popularity of minimally invasive operations among patients and healthcare providers has led to increased demand for sophisticated vascular sealing technologies.

Rising healthcare expenditure

Increased healthcare spending and continued development of healthcare infrastructure worldwide are major drivers of the vessel sealing devices market. As per Centers for Medicare and Medicaid Services, U.S. health care spending grew 4.1% to reach $4.5 Trillion in 2022, faster than the increase of 3.2% in 2021. Besides, in 2022, the insured share of the population reached 92% (a historic high). Private health insurance enrollment increased by 2.9 million individuals and Medicaid enrollment increased by 6.1 million individuals. Government and private sector expenditures in healthcare facilities, particularly in emerging nations, are leading to the construction of modern surgery centers outfitted with cutting-edge technology. This expansion improves the accessibility and affordability of advanced surgical procedures, increasing the use of vessel sealing devices. Furthermore, the focus on improving surgical results and patient safety in both developed and developing nations encourages the demand for high-performance surgical equipment, particularly vascular sealing devices.

Vessel Sealing Devices Market Segmentation:

Breakup by Product:

• Generators
• Instruments
• Accessories

Instruments accounts for the majority of the market share

Vessel sealing instruments are utilized in many different surgical procedures, including general surgery, gynecology, urology, and cardiovascular surgery. Their ability to produce consistent hemostasis and prevent intraoperative blood loss makes them essential in many complex and minimally invasive operations. The adaptability of these devices in handling diverse tissue kinds and sizes, as well as their compatibility with various surgical procedures, broadens their use range. Hence, the increasing number of surgeries is escalating the demand for vessel sealing devices, resulting in a considerable market share. As per data published by National Library of Medicine in 2020, a total of 4642 surgeries were performed per year in India for a population of 88,273. Cataract (22.8%), caesareans (3.8%), surgeries for fractures (3.27%) and hernia (2.86%) were the most common surgeries. Moreover, 44.2% of surgeries belonged to essential surgeries.

Breakup by Application:

• General Surgery
• Laparoscopic Surgery

Laparoscopic surgery holds the largest share of the industry

Advanced vascular sealing technologies considerably improve the precision and safety of laparoscopic surgery. These technologies enable surgeons to properly and swiftly seal blood arteries and tissue bundles, lowering blood loss and the risk of complications. The exact control over sealing and cutting decreases temperature diffusion to adjacent tissues, which is especially critical in the delicate and limited regions of laparoscopic surgery. This high level of precision drives the widespread adoption of vessel sealing devices in laparoscopic procedures. Besides, technological developments in both laparoscopic equipment and vascular sealing technologies have increased their popularity. Innovative features including integrated cutting and sealing capabilities, ergonomic designs, and improved energy delivery systems have considerably improved the effectiveness of vessel sealing devices.

Breakup by End User:

• Hospitals and Specialty Clinics
• Ambulatory Surgical Centers

Hospitals and specialty clinics represent the leading market segment

The rise in chronic diseases is a crucial factor driving the growth of hospitals and specialty clinics. As per Centers of Diseases Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease such as heart disease, cancer, diabetes, obesity, hypertension. Moreover, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Over the past 2 decades prevalence has increased steadily, and this trend is expected to continue. Chronic conditions such as diabetes, hypertension, cancer, and respiratory diseases require ongoing medical attention, frequent monitoring, and specialized treatments. This has led to a surge in demand for healthcare services and facilities that can manage these conditions effectively. Specialty clinics focusing on diabetes care, oncology, cardiology, and pulmonology are expanding to meet the needs of patients with chronic diseases which in turn is escalating the vessel sealing devices demand.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America leads the market, accounting for the largest vessel sealing devices market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for vessel sealing devices.

North America, especially he United States, has one of the most advanced healthcare systems in the world. The 2021 World Index on Healthcare Innovation, conducted by the Foundation for Research on Equal Opportunity (FREOPP), ranked the United States in 6th place among the world's healthcare systems. The analysis finds that the United States is a global leader in scientific advancement but that our healthcare system is fiscally unsustainable. The availability of well-equipped hospitals, specialist surgical facilities, and clinics promotes the use of innovative medical technologies, such as vascular sealing devices. Besides, the region's healthcare system invests heavily in cutting-edge equipment and technology, allowing for high-quality surgical care. Moreover, the high healthcare spending, led by both the public and private sectors, enables significant investment in medical technologies and surgical innovations.

Competitive Landscape:

• The vessel sealing devices market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the vessel sealing devices industry include B. Braun Melsungen AG, BOWA-electronic GmbH & Co. KG, Erbe Elektromedizin GmbH, Hologic Inc., Intuitive Surgical Inc., Johnson & Johnson, KLS Martin Group, Lamidey Noury Medical, Medtronic plc, Olympus Corporation, OmniGuide Holdings Inc. and Xcellance Medical Technologies Private Limited.
• Companies are making significant investments in research and development to innovate and improve their vessel sealing methods. These breakthroughs include the creation of equipment with increased energy efficiency, precision, and safety features. Besides, key competitors are making strategic acquisitions and collaborations to broaden their product ranges and market reach. Firms are also looking to increase their presence in emerging regions, where there is a growing need for improved surgical technologies. Companies are expanding their footprint by setting up manufacturing facilities, improving distribution networks, and forging local alliances.

Key Questions Answered in This Report

• 1.How big is the global vessel sealing devices market?
• 2.What is the expected growth rate of the global vessel sealing devices market during 2025-2033?
• 3.What are the key factors driving the global vessel sealing devices market?
• 4.What has been the impact of COVID-19 on the global vessel sealing devices market?
• 5.What is the breakup of the global vessel sealing devices market based on the product?
• 6.What is the breakup of the global vessel sealing devices market based on the application?
• 7.What is the breakup of the global vessel sealing devices market based on the end user?
• 8.What are the key regions in the global vessel sealing devices market?
• 9.Who are the key players/companies in the global vessel sealing devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Vessel Sealing Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Generators
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Instruments
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Accessories
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Application

• 7.1 General Surgery
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Laparoscopic Surgery
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals and Specialty Clinics
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Surgical Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 B. Braun Melsungen AG
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 SWOT Analysis
  • 14.3.2 BOWA-electronic GmbH & Co. KG
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Erbe Elektromedizin GmbH
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Hologic Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Intuitive Surgical Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Johnson & Johnson
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 KLS Martin Group
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Lamidey Noury Medical
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Medtronic plc
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Olympus Corporation
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 OmniGuide Holdings Inc.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Xcellance Medical Technologies Private Limited
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio